Illumina Body Map 2 (GSE30611)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
MIXL1
|
ENSG00000185155.12 | Mix paired-like homeobox |
GSX1
|
ENSG00000169840.5 | GS homeobox 1 |
BSX
|
ENSG00000188909.5 | brain specific homeobox |
MEOX2
|
ENSG00000106511.6 | mesenchyme homeobox 2 |
LHX4
|
ENSG00000121454.6 | LIM homeobox 4 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
GSX1 | hg38_v1_chr13_+_27792479_27792485 | -0.38 | 3.1e-02 | Click! |
LHX4 | hg38_v1_chr1_+_180230257_180230291 | -0.32 | 7.0e-02 | Click! |
MIXL1 | hg38_v1_chr1_+_226223618_226223670 | 0.10 | 5.7e-01 | Click! |
MEOX2 | hg38_v1_chr7_-_15686671_15686689 | 0.07 | 7.2e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr3_+_108822778 | 4.45 |
ENST00000295756.11
|
TRAT1
|
T cell receptor associated transmembrane adaptor 1 |
chr3_+_108822759 | 4.23 |
ENST00000426646.1
|
TRAT1
|
T cell receptor associated transmembrane adaptor 1 |
chr4_+_40196907 | 4.22 |
ENST00000622175.4
ENST00000619474.4 ENST00000615083.4 ENST00000610353.4 ENST00000614836.1 |
RHOH
|
ras homolog family member H |
chr13_-_46142834 | 4.06 |
ENST00000674665.1
|
LCP1
|
lymphocyte cytosolic protein 1 |
chr2_-_157444044 | 4.02 |
ENST00000264192.8
|
CYTIP
|
cytohesin 1 interacting protein |
chrX_+_136648138 | 3.94 |
ENST00000370629.7
|
CD40LG
|
CD40 ligand |
chr7_+_142300924 | 3.77 |
ENST00000455382.2
|
TRBV2
|
T cell receptor beta variable 2 |
chr13_-_41019289 | 3.47 |
ENST00000239882.7
|
ELF1
|
E74 like ETS transcription factor 1 |
chr15_+_58138368 | 3.36 |
ENST00000219919.9
ENST00000536493.1 |
AQP9
|
aquaporin 9 |
chr1_-_183569186 | 3.30 |
ENST00000420553.5
ENST00000419402.1 |
NCF2
|
neutrophil cytosolic factor 2 |
chr15_+_58138169 | 3.12 |
ENST00000558772.5
|
AQP9
|
aquaporin 9 |
chr7_+_142313144 | 2.90 |
ENST00000390357.3
|
TRBV4-1
|
T cell receptor beta variable 4-1 |
chr1_-_150765735 | 2.85 |
ENST00000679898.1
ENST00000448301.7 ENST00000680664.1 ENST00000679512.1 ENST00000368985.8 ENST00000679582.1 |
CTSS
|
cathepsin S |
chr19_+_49513353 | 2.78 |
ENST00000596975.5
|
FCGRT
|
Fc fragment of IgG receptor and transporter |
chr2_-_88861920 | 2.65 |
ENST00000390242.2
|
IGKJ1
|
immunoglobulin kappa joining 1 |
chr4_-_36243939 | 2.61 |
ENST00000506189.1
|
ARAP2
|
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2 |
chr1_-_92486916 | 2.55 |
ENST00000294702.6
|
GFI1
|
growth factor independent 1 transcriptional repressor |
chr14_+_22271921 | 2.52 |
ENST00000390464.2
|
TRAV38-1
|
T cell receptor alpha variable 38-1 |
chr12_+_8513499 | 2.50 |
ENST00000299665.3
|
CLEC4D
|
C-type lectin domain family 4 member D |
chr4_+_40197023 | 2.49 |
ENST00000381799.10
|
RHOH
|
ras homolog family member H |
chr1_+_174875505 | 2.33 |
ENST00000486220.5
|
RABGAP1L
|
RAB GTPase activating protein 1 like |
chr6_-_36547400 | 2.32 |
ENST00000229812.8
|
STK38
|
serine/threonine kinase 38 |
chr1_-_150765785 | 2.29 |
ENST00000680311.1
ENST00000681728.1 ENST00000680288.1 |
CTSS
|
cathepsin S |
chr17_-_40799939 | 2.28 |
ENST00000306658.8
|
KRT28
|
keratin 28 |
chr2_+_68734861 | 2.25 |
ENST00000467265.5
|
ARHGAP25
|
Rho GTPase activating protein 25 |
chr12_-_56741535 | 2.21 |
ENST00000647707.1
|
ENSG00000285625.1
|
novel protein |
chr14_+_22096017 | 2.18 |
ENST00000390452.2
|
TRDV1
|
T cell receptor delta variable 1 |
chr12_-_14950606 | 2.17 |
ENST00000536592.5
|
ARHGDIB
|
Rho GDP dissociation inhibitor beta |
chr15_+_74788542 | 2.16 |
ENST00000567571.5
|
CSK
|
C-terminal Src kinase |
chr7_+_50308672 | 2.15 |
ENST00000439701.2
ENST00000438033.5 ENST00000492782.6 |
IKZF1
|
IKAROS family zinc finger 1 |
chr7_+_116222804 | 2.10 |
ENST00000393481.6
|
TES
|
testin LIM domain protein |
chr2_+_169069537 | 2.09 |
ENST00000428522.5
ENST00000450153.1 ENST00000674881.1 ENST00000421653.5 |
DHRS9
|
dehydrogenase/reductase 9 |
chr2_+_68734773 | 2.06 |
ENST00000409202.8
|
ARHGAP25
|
Rho GTPase activating protein 25 |
chr14_-_106038355 | 2.04 |
ENST00000390597.3
|
IGHV2-5
|
immunoglobulin heavy variable 2-5 |
chr12_+_9971512 | 2.03 |
ENST00000350667.4
|
CLEC12A
|
C-type lectin domain family 12 member A |
chr7_+_142670734 | 2.01 |
ENST00000390398.3
|
TRBV25-1
|
T cell receptor beta variable 25-1 |
chr7_+_80626148 | 2.00 |
ENST00000428497.5
|
CD36
|
CD36 molecule |
chr14_+_21868822 | 1.99 |
ENST00000390436.2
|
TRAV13-1
|
T cell receptor alpha variable 13-1 |
chr2_+_90234809 | 1.99 |
ENST00000443397.5
|
IGKV3D-7
|
immunoglobulin kappa variable 3D-7 |
chrX_+_136648214 | 1.96 |
ENST00000370628.2
|
CD40LG
|
CD40 ligand |
chr2_+_90172802 | 1.95 |
ENST00000390277.3
|
IGKV3D-11
|
immunoglobulin kappa variable 3D-11 |
chr2_-_207167220 | 1.94 |
ENST00000421199.5
ENST00000457962.5 |
KLF7
|
Kruppel like factor 7 |
chr11_-_105035113 | 1.93 |
ENST00000526568.5
ENST00000531166.5 ENST00000534497.5 ENST00000527979.5 ENST00000533400.6 ENST00000528974.1 ENST00000525825.5 ENST00000353247.9 ENST00000446369.5 ENST00000436863.7 |
CASP1
|
caspase 1 |
chr10_-_29736956 | 1.88 |
ENST00000674475.1
|
SVIL
|
supervillin |
chr14_+_21997531 | 1.85 |
ENST00000390445.2
|
TRAV17
|
T cell receptor alpha variable 17 |
chr14_+_22163226 | 1.82 |
ENST00000390458.3
|
TRAV29DV5
|
T cell receptor alpha variable 29/delta variable 5 |
chr7_+_37683733 | 1.81 |
ENST00000334425.2
ENST00000450180.5 |
GPR141
|
G protein-coupled receptor 141 |
chr4_+_168092530 | 1.80 |
ENST00000359299.8
|
ANXA10
|
annexin A10 |
chr11_-_125111708 | 1.80 |
ENST00000531909.5
ENST00000529530.1 |
TMEM218
|
transmembrane protein 218 |
chr6_-_32941018 | 1.78 |
ENST00000418107.3
|
HLA-DMB
|
major histocompatibility complex, class II, DM beta |
chrX_+_123963164 | 1.78 |
ENST00000394478.1
|
STAG2
|
stromal antigen 2 |
chr17_-_59151794 | 1.66 |
ENST00000584089.1
|
SKA2
|
spindle and kinetochore associated complex subunit 2 |
chr12_+_53954870 | 1.65 |
ENST00000243103.4
|
HOXC12
|
homeobox C12 |
chr14_+_21965451 | 1.65 |
ENST00000390442.3
|
TRAV12-3
|
T cell receptor alpha variable 12-3 |
chr1_+_110873135 | 1.63 |
ENST00000271324.6
|
CD53
|
CD53 molecule |
chr2_-_213151590 | 1.63 |
ENST00000374319.8
ENST00000457361.5 ENST00000451136.6 ENST00000434687.6 |
IKZF2
|
IKAROS family zinc finger 2 |
chr6_+_26365215 | 1.62 |
ENST00000527422.5
ENST00000356386.6 ENST00000396948.5 |
BTN3A2
|
butyrophilin subfamily 3 member A2 |
chrX_-_154371210 | 1.61 |
ENST00000369856.8
ENST00000422373.6 ENST00000360319.9 |
FLNA
|
filamin A |
chr7_-_77798359 | 1.59 |
ENST00000257663.4
|
TMEM60
|
transmembrane protein 60 |
chr21_-_30881572 | 1.57 |
ENST00000332378.6
|
KRTAP11-1
|
keratin associated protein 11-1 |
chr4_+_168497113 | 1.54 |
ENST00000511948.1
|
PALLD
|
palladin, cytoskeletal associated protein |
chr3_-_27722699 | 1.54 |
ENST00000461503.2
|
EOMES
|
eomesodermin |
chr4_+_36281591 | 1.52 |
ENST00000639862.2
ENST00000357504.7 |
DTHD1
|
death domain containing 1 |
chr5_-_143400716 | 1.51 |
ENST00000424646.6
ENST00000652686.1 |
NR3C1
|
nuclear receptor subfamily 3 group C member 1 |
chr13_-_99258366 | 1.48 |
ENST00000397470.5
ENST00000397473.7 |
GPR18
|
G protein-coupled receptor 18 |
chr6_+_26365176 | 1.47 |
ENST00000377708.7
|
BTN3A2
|
butyrophilin subfamily 3 member A2 |
chr1_-_113871665 | 1.46 |
ENST00000528414.5
ENST00000460620.5 ENST00000359785.10 ENST00000420377.6 ENST00000525799.1 ENST00000538253.5 |
PTPN22
|
protein tyrosine phosphatase non-receptor type 22 |
chr6_+_113857333 | 1.46 |
ENST00000612661.2
|
MARCKS
|
myristoylated alanine rich protein kinase C substrate |
chr1_+_100538131 | 1.46 |
ENST00000315033.5
|
GPR88
|
G protein-coupled receptor 88 |
chr1_+_198638723 | 1.45 |
ENST00000643513.1
|
PTPRC
|
protein tyrosine phosphatase receptor type C |
chr14_+_22462932 | 1.44 |
ENST00000390477.2
|
TRDC
|
T cell receptor delta constant |
chr16_+_11965193 | 1.44 |
ENST00000053243.6
ENST00000396495.3 |
TNFRSF17
|
TNF receptor superfamily member 17 |
chrX_-_19799751 | 1.42 |
ENST00000379698.8
|
SH3KBP1
|
SH3 domain containing kinase binding protein 1 |
chr8_+_32614361 | 1.41 |
ENST00000522569.1
|
NRG1
|
neuregulin 1 |
chr6_+_106360668 | 1.40 |
ENST00000633556.3
|
CRYBG1
|
crystallin beta-gamma domain containing 1 |
chr15_-_55270280 | 1.38 |
ENST00000564609.5
|
RAB27A
|
RAB27A, member RAS oncogene family |
chr5_-_39219555 | 1.38 |
ENST00000512982.4
ENST00000351578.12 ENST00000509072.5 ENST00000504542.1 ENST00000506557.5 |
FYB1
|
FYN binding protein 1 |
chr3_+_122055355 | 1.38 |
ENST00000330540.7
ENST00000469710.5 ENST00000493101.5 |
CD86
|
CD86 molecule |
chr2_+_87338511 | 1.36 |
ENST00000421835.2
|
IGKV3OR2-268
|
immunoglobulin kappa variable 3/OR2-268 (non-functional) |
chr1_+_198638457 | 1.36 |
ENST00000367379.6
|
PTPRC
|
protein tyrosine phosphatase receptor type C |
chr12_-_9999176 | 1.33 |
ENST00000298527.10
ENST00000348658.4 |
CLEC1B
|
C-type lectin domain family 1 member B |
chr12_+_55932028 | 1.32 |
ENST00000394147.5
ENST00000551156.5 ENST00000553783.5 ENST00000557080.5 ENST00000432422.7 ENST00000556001.5 |
DGKA
|
diacylglycerol kinase alpha |
chr2_+_17816458 | 1.29 |
ENST00000281047.4
|
MSGN1
|
mesogenin 1 |
chr5_+_67004618 | 1.29 |
ENST00000261569.11
ENST00000436277.5 |
MAST4
|
microtubule associated serine/threonine kinase family member 4 |
chr1_+_198638968 | 1.28 |
ENST00000348564.11
ENST00000530727.5 ENST00000442510.8 ENST00000645247.1 ENST00000367367.8 ENST00000367364.5 ENST00000413409.6 |
PTPRC
|
protein tyrosine phosphatase receptor type C |
chr15_+_76336755 | 1.28 |
ENST00000290759.9
|
ISL2
|
ISL LIM homeobox 2 |
chr1_+_154429315 | 1.27 |
ENST00000476006.5
|
IL6R
|
interleukin 6 receptor |
chr4_+_40200320 | 1.27 |
ENST00000511121.5
|
RHOH
|
ras homolog family member H |
chr15_-_55270383 | 1.27 |
ENST00000396307.6
|
RAB27A
|
RAB27A, member RAS oncogene family |
chr4_-_152679984 | 1.25 |
ENST00000304385.8
ENST00000504064.1 |
TMEM154
|
transmembrane protein 154 |
chr3_-_27722316 | 1.21 |
ENST00000449599.4
|
EOMES
|
eomesodermin |
chr2_-_144520006 | 1.21 |
ENST00000303660.8
|
ZEB2
|
zinc finger E-box binding homeobox 2 |
chr15_-_55270874 | 1.20 |
ENST00000567380.5
ENST00000565972.5 ENST00000569493.5 |
RAB27A
|
RAB27A, member RAS oncogene family |
chr9_+_133636355 | 1.20 |
ENST00000393056.8
|
DBH
|
dopamine beta-hydroxylase |
chr14_+_61187544 | 1.19 |
ENST00000555185.5
ENST00000557294.5 ENST00000556778.5 |
PRKCH
|
protein kinase C eta |
chr17_-_41034871 | 1.19 |
ENST00000344363.7
|
KRTAP1-3
|
keratin associated protein 1-3 |
chr11_-_4697831 | 1.19 |
ENST00000641159.1
ENST00000396950.4 ENST00000532598.1 |
OR51C1P
OR51E2
|
olfactory receptor family 51 subfamily C member 1 pseudogene olfactory receptor family 51 subfamily E member 2 |
chr11_-_2301859 | 1.19 |
ENST00000456145.2
ENST00000381153.8 |
C11orf21
|
chromosome 11 open reading frame 21 |
chrX_+_135520616 | 1.17 |
ENST00000370752.4
ENST00000639893.2 |
INTS6L
|
integrator complex subunit 6 like |
chr2_+_206159580 | 1.16 |
ENST00000236957.9
ENST00000392221.5 ENST00000445505.5 |
EEF1B2
|
eukaryotic translation elongation factor 1 beta 2 |
chr1_-_169703329 | 1.16 |
ENST00000497295.1
|
SELL
|
selectin L |
chr9_+_133636378 | 1.15 |
ENST00000263611.3
|
DBH
|
dopamine beta-hydroxylase |
chr9_+_122370523 | 1.14 |
ENST00000643810.1
ENST00000540753.6 |
PTGS1
|
prostaglandin-endoperoxide synthase 1 |
chrX_+_37780049 | 1.14 |
ENST00000378588.5
|
CYBB
|
cytochrome b-245 beta chain |
chr1_-_24964984 | 1.12 |
ENST00000338888.3
ENST00000399916.5 |
RUNX3
|
RUNX family transcription factor 3 |
chr15_-_55270249 | 1.12 |
ENST00000568803.1
|
RAB27A
|
RAB27A, member RAS oncogene family |
chr1_-_17439657 | 1.11 |
ENST00000375436.9
|
RCC2
|
regulator of chromosome condensation 2 |
chr6_-_32816910 | 1.11 |
ENST00000447394.1
ENST00000438763.7 |
HLA-DOB
|
major histocompatibility complex, class II, DO beta |
chr10_-_114632011 | 1.09 |
ENST00000651023.1
|
ABLIM1
|
actin binding LIM protein 1 |
chr4_-_142305935 | 1.09 |
ENST00000511838.5
|
INPP4B
|
inositol polyphosphate-4-phosphatase type II B |
chr12_-_16277685 | 1.08 |
ENST00000344941.3
|
SLC15A5
|
solute carrier family 15 member 5 |
chr15_+_85544036 | 1.06 |
ENST00000558166.2
|
AKAP13
|
A-kinase anchoring protein 13 |
chr7_-_93148345 | 1.06 |
ENST00000437805.5
ENST00000446959.5 ENST00000439952.5 ENST00000414791.5 ENST00000446033.1 ENST00000411955.5 ENST00000318238.9 |
SAMD9L
|
sterile alpha motif domain containing 9 like |
chr1_-_153545793 | 1.05 |
ENST00000354332.8
ENST00000368716.9 |
S100A4
|
S100 calcium binding protein A4 |
chr11_+_60455839 | 1.05 |
ENST00000532491.5
ENST00000532073.5 ENST00000345732.9 ENST00000534668.6 ENST00000528313.1 ENST00000533306.6 ENST00000674194.1 |
MS4A1
|
membrane spanning 4-domains A1 |
chr2_+_203706475 | 1.05 |
ENST00000374481.7
ENST00000458610.6 |
CD28
|
CD28 molecule |
chr12_+_64405046 | 1.04 |
ENST00000540203.5
|
XPOT
|
exportin for tRNA |
chr6_+_130018565 | 1.02 |
ENST00000361794.7
ENST00000526087.5 ENST00000533560.5 |
L3MBTL3
|
L3MBTL histone methyl-lysine binding protein 3 |
chr6_+_6588082 | 1.02 |
ENST00000379953.6
|
LY86
|
lymphocyte antigen 86 |
chr2_+_203706614 | 0.99 |
ENST00000324106.9
|
CD28
|
CD28 molecule |
chr4_-_142305826 | 0.99 |
ENST00000514525.1
|
INPP4B
|
inositol polyphosphate-4-phosphatase type II B |
chr17_+_74935892 | 0.97 |
ENST00000328801.6
|
OTOP3
|
otopetrin 3 |
chr14_+_92323154 | 0.97 |
ENST00000532405.6
ENST00000676001.1 ENST00000531433.5 |
SLC24A4
|
solute carrier family 24 member 4 |
chr10_+_70404129 | 0.97 |
ENST00000373218.5
|
EIF4EBP2
|
eukaryotic translation initiation factor 4E binding protein 2 |
chr6_+_26365159 | 0.97 |
ENST00000532865.5
ENST00000396934.7 ENST00000508906.6 ENST00000530653.5 ENST00000527417.5 |
BTN3A2
|
butyrophilin subfamily 3 member A2 |
chr10_+_102503956 | 0.97 |
ENST00000369902.8
|
SUFU
|
SUFU negative regulator of hedgehog signaling |
chr1_+_40374648 | 0.96 |
ENST00000372708.5
|
SMAP2
|
small ArfGAP2 |
chr1_-_157777124 | 0.96 |
ENST00000361516.8
ENST00000368181.4 |
FCRL2
|
Fc receptor like 2 |
chr9_+_122371014 | 0.96 |
ENST00000362012.7
|
PTGS1
|
prostaglandin-endoperoxide synthase 1 |
chr10_+_17228215 | 0.96 |
ENST00000544301.7
|
VIM
|
vimentin |
chr2_+_90038848 | 0.95 |
ENST00000390270.2
|
IGKV3D-20
|
immunoglobulin kappa variable 3D-20 |
chr2_-_88947820 | 0.95 |
ENST00000496168.1
|
IGKV1-5
|
immunoglobulin kappa variable 1-5 |
chr16_+_68085552 | 0.95 |
ENST00000329524.8
|
NFATC3
|
nuclear factor of activated T cells 3 |
chr12_+_55931447 | 0.95 |
ENST00000549368.5
|
DGKA
|
diacylglycerol kinase alpha |
chr1_+_74235377 | 0.95 |
ENST00000326637.8
|
TNNI3K
|
TNNI3 interacting kinase |
chr15_-_60391127 | 0.95 |
ENST00000559350.5
ENST00000558986.5 ENST00000560389.5 |
ANXA2
|
annexin A2 |
chr12_-_9607903 | 0.94 |
ENST00000229402.4
|
KLRB1
|
killer cell lectin like receptor B1 |
chr9_+_122371036 | 0.93 |
ENST00000619306.5
ENST00000426608.6 ENST00000223423.8 |
PTGS1
|
prostaglandin-endoperoxide synthase 1 |
chr14_+_21712313 | 0.92 |
ENST00000390424.2
|
TRAV2
|
T cell receptor alpha variable 2 |
chr13_-_94479671 | 0.92 |
ENST00000377028.10
ENST00000446125.1 |
DCT
|
dopachrome tautomerase |
chr18_+_34976928 | 0.92 |
ENST00000591734.5
ENST00000413393.5 ENST00000589180.5 ENST00000587359.5 |
MAPRE2
|
microtubule associated protein RP/EB family member 2 |
chr6_-_65707214 | 0.91 |
ENST00000370621.7
ENST00000393380.6 ENST00000503581.6 |
EYS
|
eyes shut homolog |
chr6_+_139135063 | 0.91 |
ENST00000367658.3
|
HECA
|
hdc homolog, cell cycle regulator |
chr12_-_89352395 | 0.90 |
ENST00000308385.6
|
DUSP6
|
dual specificity phosphatase 6 |
chr2_+_206159884 | 0.90 |
ENST00000392222.7
|
EEF1B2
|
eukaryotic translation elongation factor 1 beta 2 |
chr4_-_70666492 | 0.89 |
ENST00000254801.9
ENST00000391614.7 |
JCHAIN
|
joining chain of multimeric IgA and IgM |
chr14_+_22422371 | 0.88 |
ENST00000390469.2
|
TRDV2
|
T cell receptor delta variable 2 |
chr12_-_89352487 | 0.88 |
ENST00000548755.1
ENST00000279488.8 |
DUSP6
|
dual specificity phosphatase 6 |
chr4_+_26322850 | 0.88 |
ENST00000514675.5
|
RBPJ
|
recombination signal binding protein for immunoglobulin kappa J region |
chr21_-_14658812 | 0.87 |
ENST00000647101.1
|
SAMSN1
|
SAM domain, SH3 domain and nuclear localization signals 1 |
chr6_+_135181361 | 0.87 |
ENST00000527615.5
ENST00000420123.6 ENST00000525369.5 ENST00000528774.5 ENST00000533624.5 ENST00000534044.5 ENST00000534121.5 |
MYB
|
MYB proto-oncogene, transcription factor |
chr14_+_20781139 | 0.87 |
ENST00000304677.3
|
RNASE6
|
ribonuclease A family member k6 |
chr14_+_21924033 | 0.87 |
ENST00000390440.2
|
TRAV14DV4
|
T cell receptor alpha variable 14/delta variable 4 |
chr7_-_80512041 | 0.87 |
ENST00000398291.4
|
GNAT3
|
G protein subunit alpha transducin 3 |
chr8_-_42377227 | 0.86 |
ENST00000220812.3
|
DKK4
|
dickkopf WNT signaling pathway inhibitor 4 |
chr4_+_70518583 | 0.86 |
ENST00000504451.1
|
AMTN
|
amelotin |
chr6_+_31615984 | 0.86 |
ENST00000376049.4
|
AIF1
|
allograft inflammatory factor 1 |
chr7_-_83648547 | 0.85 |
ENST00000642232.1
|
SEMA3E
|
semaphorin 3E |
chr17_-_41047267 | 0.84 |
ENST00000542137.1
ENST00000391419.3 |
KRTAP2-1
|
keratin associated protein 2-1 |
chr17_-_40755328 | 0.84 |
ENST00000312150.5
|
KRT25
|
keratin 25 |
chr3_-_165078480 | 0.83 |
ENST00000264382.8
|
SI
|
sucrase-isomaltase |
chr2_-_88861563 | 0.83 |
ENST00000624935.3
ENST00000390241.3 |
ENSG00000240040.6
IGKJ2
|
novel transcript immunoglobulin kappa joining 2 |
chr18_+_23992773 | 0.83 |
ENST00000304621.10
|
TTC39C
|
tetratricopeptide repeat domain 39C |
chr18_+_3247778 | 0.83 |
ENST00000217652.8
ENST00000578611.5 ENST00000583449.1 |
MYL12A
|
myosin light chain 12A |
chr4_-_25863537 | 0.83 |
ENST00000502949.5
ENST00000264868.9 ENST00000513691.1 ENST00000514872.1 |
SEL1L3
|
SEL1L family member 3 |
chr8_+_38974212 | 0.82 |
ENST00000302495.5
|
HTRA4
|
HtrA serine peptidase 4 |
chr4_-_88284590 | 0.82 |
ENST00000510548.6
|
PPM1K
|
protein phosphatase, Mg2+/Mn2+ dependent 1K |
chr1_+_170145959 | 0.80 |
ENST00000439373.3
|
METTL11B
|
methyltransferase like 11B |
chr6_+_26402237 | 0.79 |
ENST00000476549.6
ENST00000450085.6 ENST00000425234.6 ENST00000427334.5 ENST00000506698.1 ENST00000289361.11 |
BTN3A1
|
butyrophilin subfamily 3 member A1 |
chr2_-_89143133 | 0.79 |
ENST00000492167.1
|
IGKV3-20
|
immunoglobulin kappa variable 3-20 |
chr18_+_63887698 | 0.78 |
ENST00000457692.5
ENST00000299502.9 ENST00000413956.5 |
SERPINB2
|
serpin family B member 2 |
chr8_-_100722731 | 0.77 |
ENST00000521865.6
ENST00000520804.2 ENST00000522720.2 ENST00000521067.1 |
PABPC1
|
poly(A) binding protein cytoplasmic 1 |
chr11_-_120138031 | 0.77 |
ENST00000627238.1
|
TRIM29
|
tripartite motif containing 29 |
chr2_-_181680490 | 0.77 |
ENST00000684145.1
ENST00000295108.4 ENST00000684079.1 ENST00000683430.1 |
CERKL
NEUROD1
|
ceramide kinase like neuronal differentiation 1 |
chr6_-_116545658 | 0.77 |
ENST00000368602.4
|
TRAPPC3L
|
trafficking protein particle complex 3 like |
chr1_+_226063466 | 0.76 |
ENST00000666609.1
ENST00000661429.1 |
H3-3A
|
H3.3 histone A |
chr1_-_157820060 | 0.76 |
ENST00000491942.1
ENST00000358292.7 |
FCRL1
|
Fc receptor like 1 |
chr2_-_108989206 | 0.76 |
ENST00000258443.7
ENST00000409271.5 ENST00000376651.1 |
EDAR
|
ectodysplasin A receptor |
chr4_-_15681454 | 0.76 |
ENST00000507899.1
ENST00000510802.5 |
FBXL5
|
F-box and leucine rich repeat protein 5 |
chr11_+_60056587 | 0.75 |
ENST00000395032.6
ENST00000358152.6 |
MS4A3
|
membrane spanning 4-domains A3 |
chr7_+_100119607 | 0.75 |
ENST00000262932.5
|
CNPY4
|
canopy FGF signaling regulator 4 |
chr2_-_162152404 | 0.74 |
ENST00000375497.3
|
GCG
|
glucagon |
chr2_-_157488829 | 0.74 |
ENST00000435117.1
ENST00000439355.5 |
CYTIP
|
cytohesin 1 interacting protein |
chr6_-_26234978 | 0.74 |
ENST00000244534.7
|
H1-3
|
H1.3 linker histone, cluster member |
chr7_+_18290089 | 0.74 |
ENST00000433709.6
|
HDAC9
|
histone deacetylase 9 |
chr3_-_18438767 | 0.73 |
ENST00000454909.6
|
SATB1
|
SATB homeobox 1 |
chr19_-_55464741 | 0.73 |
ENST00000635964.2
|
C19orf85
|
chromosome 19 open reading frame 85 |
chr19_+_55600277 | 0.73 |
ENST00000301073.4
|
ZNF524
|
zinc finger protein 524 |
chr6_-_31139063 | 0.73 |
ENST00000259845.5
|
PSORS1C2
|
psoriasis susceptibility 1 candidate 2 |
chr3_-_143848442 | 0.72 |
ENST00000474151.1
ENST00000316549.11 |
SLC9A9
|
solute carrier family 9 member A9 |
chr5_+_138337511 | 0.72 |
ENST00000434981.6
|
FAM53C
|
family with sequence similarity 53 member C |
chr10_-_49188312 | 0.72 |
ENST00000453436.5
ENST00000474718.5 |
TMEM273
|
transmembrane protein 273 |
chr9_-_128724088 | 0.72 |
ENST00000406904.2
ENST00000452105.5 ENST00000372667.9 ENST00000372663.9 |
ZDHHC12
|
zinc finger DHHC-type palmitoyltransferase 12 |
chr3_+_159069309 | 0.71 |
ENST00000397832.7
ENST00000451172.5 ENST00000482126.1 |
IQCJ
|
IQ motif containing J |
chr19_-_45584769 | 0.71 |
ENST00000263275.5
|
OPA3
|
outer mitochondrial membrane lipid metabolism regulator OPA3 |
chr2_-_89085787 | 0.71 |
ENST00000390252.2
|
IGKV3-15
|
immunoglobulin kappa variable 3-15 |
chr5_+_179732811 | 0.69 |
ENST00000292599.4
|
MAML1
|
mastermind like transcriptional coactivator 1 |
chr3_+_141387616 | 0.69 |
ENST00000509883.5
|
ZBTB38
|
zinc finger and BTB domain containing 38 |
chr1_-_157820113 | 0.69 |
ENST00000368176.8
|
FCRL1
|
Fc receptor like 1 |
chr6_+_26402289 | 0.69 |
ENST00000414912.2
|
BTN3A1
|
butyrophilin subfamily 3 member A1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 5.1 | GO:0034769 | basement membrane disassembly(GO:0034769) |
1.3 | 6.5 | GO:1904823 | pyrimidine nucleobase transport(GO:0015855) purine nucleobase transmembrane transport(GO:1904823) |
1.1 | 8.0 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
1.1 | 3.2 | GO:0002416 | IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor(GO:0002416) |
0.9 | 4.7 | GO:2000473 | regulation of hematopoietic stem cell migration(GO:2000471) positive regulation of hematopoietic stem cell migration(GO:2000473) |
0.9 | 2.8 | GO:0002302 | CD8-positive, alpha-beta T cell differentiation involved in immune response(GO:0002302) |
0.9 | 2.6 | GO:0070105 | positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
0.8 | 2.4 | GO:0006589 | octopamine biosynthetic process(GO:0006589) homoiothermy(GO:0042309) octopamine metabolic process(GO:0046333) |
0.7 | 5.0 | GO:1903435 | positive regulation of constitutive secretory pathway(GO:1903435) |
0.6 | 1.9 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.6 | 1.8 | GO:0002503 | peptide antigen assembly with MHC class II protein complex(GO:0002503) |
0.5 | 1.5 | GO:0002304 | gamma-delta intraepithelial T cell differentiation(GO:0002304) CD8-positive, gamma-delta intraepithelial T cell differentiation(GO:0002305) |
0.5 | 1.4 | GO:0043017 | negative regulation of T cell tolerance induction(GO:0002665) negative regulation of T cell anergy(GO:0002668) negative regulation of lymphocyte anergy(GO:0002912) regulation of lymphotoxin A production(GO:0032681) positive regulation of lymphotoxin A production(GO:0032761) regulation of lymphotoxin A biosynthetic process(GO:0043016) positive regulation of lymphotoxin A biosynthetic process(GO:0043017) |
0.4 | 1.3 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.4 | 1.2 | GO:0070175 | positive regulation of enamel mineralization(GO:0070175) |
0.4 | 1.2 | GO:0043973 | histone H3-K4 acetylation(GO:0043973) |
0.4 | 1.2 | GO:1900135 | positive regulation of renin secretion into blood stream(GO:1900135) |
0.4 | 1.2 | GO:1904899 | regulation of hepatic stellate cell proliferation(GO:1904897) positive regulation of hepatic stellate cell proliferation(GO:1904899) hepatic stellate cell proliferation(GO:1990922) |
0.4 | 1.1 | GO:1904845 | response to L-glutamine(GO:1904844) cellular response to L-glutamine(GO:1904845) |
0.4 | 1.1 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
0.4 | 2.2 | GO:0071461 | cellular response to redox state(GO:0071461) |
0.4 | 1.8 | GO:0042663 | regulation of endodermal cell fate specification(GO:0042663) |
0.3 | 4.4 | GO:2000332 | response to linoleic acid(GO:0070543) blood microparticle formation(GO:0072564) regulation of blood microparticle formation(GO:2000332) positive regulation of blood microparticle formation(GO:2000334) |
0.3 | 1.6 | GO:1905000 | regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
0.3 | 2.2 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
0.3 | 1.5 | GO:1902523 | positive regulation of protein K63-linked ubiquitination(GO:1902523) |
0.3 | 0.8 | GO:0060730 | regulation of intestinal epithelial structure maintenance(GO:0060730) |
0.3 | 1.3 | GO:0002384 | hepatic immune response(GO:0002384) |
0.2 | 0.9 | GO:0052227 | multi-organism catabolic process(GO:0044035) development of symbiont involved in interaction with host(GO:0044115) modulation of development of symbiont involved in interaction with host(GO:0044145) negative regulation of development of symbiont involved in interaction with host(GO:0044147) metabolism of substance in other organism involved in symbiotic interaction(GO:0052214) catabolism of substance in other organism involved in symbiotic interaction(GO:0052227) metabolism of macromolecule in other organism involved in symbiotic interaction(GO:0052229) catabolism by host of symbiont macromolecule(GO:0052360) catabolism by organism of macromolecule in other organism involved in symbiotic interaction(GO:0052361) catabolism by host of symbiont protein(GO:0052362) catabolism by organism of protein in other organism involved in symbiotic interaction(GO:0052363) catabolism by host of substance in symbiont(GO:0052364) metabolism by host of symbiont macromolecule(GO:0052416) metabolism by host of symbiont protein(GO:0052417) metabolism by organism of protein in other organism involved in symbiotic interaction(GO:0052418) metabolism by host of substance in symbiont(GO:0052419) |
0.2 | 5.9 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.2 | 0.7 | GO:1990451 | cellular stress response to acidic pH(GO:1990451) |
0.2 | 2.1 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.2 | 0.9 | GO:0050883 | musculoskeletal movement, spinal reflex action(GO:0050883) |
0.2 | 0.6 | GO:0061017 | hepatic duct development(GO:0061011) hepatoblast differentiation(GO:0061017) |
0.2 | 0.6 | GO:0075732 | viral penetration into host nucleus(GO:0075732) multi-organism nuclear import(GO:1902594) |
0.2 | 1.5 | GO:0061743 | motor learning(GO:0061743) |
0.2 | 0.4 | GO:2000724 | positive regulation of cardiac vascular smooth muscle cell differentiation(GO:2000724) |
0.2 | 0.6 | GO:0048561 | establishment of organ orientation(GO:0048561) |
0.2 | 0.8 | GO:0006480 | N-terminal protein amino acid methylation(GO:0006480) |
0.2 | 1.3 | GO:0021775 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
0.2 | 0.2 | GO:0000294 | nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
0.2 | 2.4 | GO:1902748 | positive regulation of lens fiber cell differentiation(GO:1902748) |
0.2 | 4.5 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.2 | 0.7 | GO:0003292 | cardiac septum cell differentiation(GO:0003292) atrioventricular node cell differentiation(GO:0060922) atrioventricular node cell development(GO:0060928) |
0.2 | 0.8 | GO:0035513 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
0.2 | 0.3 | GO:2000523 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.2 | 0.5 | GO:1904211 | membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
0.2 | 0.9 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
0.2 | 0.6 | GO:0052027 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
0.2 | 0.5 | GO:0003218 | cardiac left ventricle formation(GO:0003218) |
0.2 | 3.0 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.2 | 5.6 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
0.2 | 2.6 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
0.1 | 2.0 | GO:0002863 | positive regulation of inflammatory response to antigenic stimulus(GO:0002863) |
0.1 | 0.1 | GO:0090402 | oncogene-induced cell senescence(GO:0090402) |
0.1 | 0.9 | GO:0051799 | negative regulation of hair follicle development(GO:0051799) |
0.1 | 0.5 | GO:1903936 | cellular response to sodium arsenite(GO:1903936) |
0.1 | 1.1 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
0.1 | 0.5 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.1 | 1.0 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.1 | 1.5 | GO:0034350 | regulation of glial cell apoptotic process(GO:0034350) negative regulation of glial cell apoptotic process(GO:0034351) |
0.1 | 0.4 | GO:0086092 | regulation of the force of heart contraction by cardiac conduction(GO:0086092) |
0.1 | 0.9 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.1 | 0.7 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
0.1 | 0.9 | GO:0014738 | regulation of muscle hyperplasia(GO:0014738) |
0.1 | 0.6 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.1 | 0.8 | GO:0060332 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.1 | 0.7 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.1 | 0.5 | GO:0001868 | regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
0.1 | 0.8 | GO:0060662 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.1 | 4.2 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.1 | 0.5 | GO:0061357 | positive regulation of Wnt protein secretion(GO:0061357) |
0.1 | 0.6 | GO:0032796 | uropod organization(GO:0032796) |
0.1 | 0.3 | GO:1990579 | protein trans-autophosphorylation(GO:0036290) peptidyl-serine trans-autophosphorylation(GO:1990579) |
0.1 | 0.8 | GO:0097026 | dendritic cell dendrite assembly(GO:0097026) |
0.1 | 0.5 | GO:0002881 | negative regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002881) |
0.1 | 1.8 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.1 | 0.8 | GO:0044245 | polysaccharide digestion(GO:0044245) |
0.1 | 0.3 | GO:1903259 | exon-exon junction complex disassembly(GO:1903259) |
0.1 | 1.1 | GO:0060005 | vestibular reflex(GO:0060005) |
0.1 | 1.0 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
0.1 | 0.6 | GO:2001107 | negative regulation of establishment of T cell polarity(GO:1903904) negative regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001107) |
0.1 | 1.1 | GO:1901295 | arterial endothelial cell fate commitment(GO:0060844) positive regulation of ephrin receptor signaling pathway(GO:1901189) regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:1901295) positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:1901297) regulation of canonical Wnt signaling pathway involved in heart development(GO:1905066) positive regulation of canonical Wnt signaling pathway involved in heart development(GO:1905068) |
0.1 | 0.6 | GO:1902952 | positive regulation of dendritic spine maintenance(GO:1902952) |
0.1 | 0.5 | GO:1904468 | negative regulation of tumor necrosis factor secretion(GO:1904468) |
0.1 | 0.6 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.1 | 0.3 | GO:1905246 | regulation of choline O-acetyltransferase activity(GO:1902769) positive regulation of choline O-acetyltransferase activity(GO:1902771) negative regulation of tau-protein kinase activity(GO:1902948) positive regulation of early endosome to recycling endosome transport(GO:1902955) negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902960) negative regulation of neurofibrillary tangle assembly(GO:1902997) negative regulation of aspartic-type peptidase activity(GO:1905246) |
0.1 | 0.3 | GO:0035038 | female pronucleus assembly(GO:0035038) |
0.1 | 0.3 | GO:1904907 | negative regulation of maintenance of sister chromatid cohesion(GO:0034092) negative regulation of maintenance of mitotic sister chromatid cohesion(GO:0034183) maintenance of mitotic sister chromatid cohesion, telomeric(GO:0099403) mitotic sister chromatid cohesion, telomeric(GO:0099404) regulation of maintenance of mitotic sister chromatid cohesion, telomeric(GO:1904907) negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric(GO:1904908) |
0.1 | 0.4 | GO:0043091 | L-arginine import(GO:0043091) arginine import(GO:0090467) |
0.1 | 0.3 | GO:0030187 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
0.1 | 0.5 | GO:1901994 | negative regulation of meiotic cell cycle phase transition(GO:1901994) |
0.1 | 1.4 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.1 | 0.3 | GO:0070839 | spleen trabecula formation(GO:0060345) divalent metal ion export(GO:0070839) iron cation export(GO:1903414) ferrous iron export(GO:1903988) |
0.1 | 0.3 | GO:0061182 | negative regulation of chondrocyte development(GO:0061182) |
0.1 | 0.9 | GO:0021847 | ventricular zone neuroblast division(GO:0021847) |
0.1 | 1.6 | GO:0021842 | directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) ERBB3 signaling pathway(GO:0038129) |
0.1 | 0.5 | GO:1904428 | negative regulation of tubulin deacetylation(GO:1904428) |
0.1 | 3.7 | GO:0045730 | respiratory burst(GO:0045730) |
0.1 | 0.5 | GO:0002729 | positive regulation of natural killer cell cytokine production(GO:0002729) |
0.1 | 0.3 | GO:1903676 | regulation of cap-dependent translational initiation(GO:1903674) positive regulation of cap-dependent translational initiation(GO:1903676) |
0.1 | 0.3 | GO:1903045 | neural crest cell migration involved in sympathetic nervous system development(GO:1903045) |
0.1 | 0.3 | GO:2000296 | negative regulation of hydrogen peroxide catabolic process(GO:2000296) |
0.1 | 7.7 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.1 | 0.2 | GO:0000354 | cis assembly of pre-catalytic spliceosome(GO:0000354) |
0.1 | 1.2 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.1 | 1.5 | GO:0030202 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
0.1 | 0.1 | GO:0018153 | isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
0.1 | 0.5 | GO:0018032 | protein amidation(GO:0018032) |
0.1 | 2.0 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
0.1 | 0.5 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.1 | 0.5 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.1 | 1.5 | GO:1990001 | inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.1 | 0.6 | GO:0035696 | monocyte extravasation(GO:0035696) |
0.1 | 0.3 | GO:0042335 | cuticle development(GO:0042335) |
0.1 | 0.7 | GO:0097338 | response to clozapine(GO:0097338) |
0.1 | 0.4 | GO:2000005 | apoptotic process involved in endocardial cushion morphogenesis(GO:0003277) intermediate mesoderm morphogenesis(GO:0048390) intermediate mesoderm formation(GO:0048391) intermediate mesodermal cell differentiation(GO:0048392) regulation of cardiac muscle fiber development(GO:0055018) positive regulation of cardiac muscle fiber development(GO:0055020) bud dilation involved in lung branching(GO:0060503) BMP signaling pathway involved in ureter morphogenesis(GO:0061149) renal system segmentation(GO:0061150) BMP signaling pathway involved in renal system segmentation(GO:0061151) pulmonary artery endothelial tube morphogenesis(GO:0061155) regulation of transcription from RNA polymerase II promoter involved in mesonephros development(GO:0061216) BMP signaling pathway involved in nephric duct formation(GO:0071893) negative regulation of branch elongation involved in ureteric bud branching(GO:0072096) negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway(GO:0072097) anterior/posterior pattern specification involved in ureteric bud development(GO:0072099) specification of ureteric bud anterior/posterior symmetry(GO:0072100) specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway(GO:0072101) ureter epithelial cell differentiation(GO:0072192) negative regulation of mesenchymal cell proliferation involved in ureter development(GO:0072200) positive regulation of cell proliferation involved in outflow tract morphogenesis(GO:1901964) cardiac jelly development(GO:1905072) regulation of metanephric S-shaped body morphogenesis(GO:2000004) negative regulation of metanephric S-shaped body morphogenesis(GO:2000005) regulation of metanephric comma-shaped body morphogenesis(GO:2000006) negative regulation of metanephric comma-shaped body morphogenesis(GO:2000007) |
0.1 | 0.6 | GO:1904879 | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
0.1 | 0.9 | GO:1900625 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
0.1 | 1.4 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.1 | 0.6 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.1 | 0.4 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
0.1 | 2.0 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.1 | 1.4 | GO:0072015 | glomerular visceral epithelial cell development(GO:0072015) |
0.1 | 14.6 | GO:0002377 | immunoglobulin production(GO:0002377) |
0.1 | 0.2 | GO:1990637 | response to prolactin(GO:1990637) regulation of ovarian follicle development(GO:2000354) |
0.1 | 2.1 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.1 | 0.3 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
0.1 | 2.4 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.1 | 0.2 | GO:0048058 | compound eye corneal lens development(GO:0048058) |
0.1 | 0.5 | GO:0007296 | vitellogenesis(GO:0007296) |
0.1 | 0.3 | GO:0061534 | gamma-aminobutyric acid secretion, neurotransmission(GO:0061534) |
0.1 | 1.2 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.1 | 0.1 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
0.1 | 0.9 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.1 | 0.5 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.1 | 0.3 | GO:1990168 | protein K33-linked deubiquitination(GO:1990168) |
0.1 | 0.2 | GO:1903015 | regulation of exo-alpha-sialidase activity(GO:1903015) |
0.1 | 0.3 | GO:0035026 | leading edge cell differentiation(GO:0035026) |
0.1 | 1.2 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.1 | 0.4 | GO:0051697 | protein delipidation(GO:0051697) |
0.1 | 0.3 | GO:0030573 | bile acid catabolic process(GO:0030573) |
0.1 | 0.2 | GO:0071140 | resolution of recombination intermediates(GO:0071139) resolution of mitotic recombination intermediates(GO:0071140) |
0.1 | 0.5 | GO:0048840 | otolith development(GO:0048840) |
0.1 | 0.3 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.1 | 1.1 | GO:0032625 | interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
0.1 | 0.5 | GO:0061087 | regulation of histone H3-K27 methylation(GO:0061085) positive regulation of histone H3-K27 methylation(GO:0061087) |
0.1 | 0.2 | GO:1905044 | Schwann cell proliferation involved in axon regeneration(GO:0014011) negative regulation of Schwann cell migration(GO:1900148) regulation of Schwann cell proliferation involved in axon regeneration(GO:1905044) negative regulation of Schwann cell proliferation involved in axon regeneration(GO:1905045) |
0.1 | 0.2 | GO:0036292 | DNA rewinding(GO:0036292) |
0.1 | 0.5 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
0.1 | 0.9 | GO:0086069 | bundle of His cell to Purkinje myocyte communication(GO:0086069) |
0.1 | 0.2 | GO:0018874 | benzoate metabolic process(GO:0018874) |
0.1 | 1.4 | GO:0003334 | keratinocyte development(GO:0003334) |
0.1 | 1.2 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.1 | 0.6 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.1 | 0.1 | GO:0002399 | MHC class II protein complex assembly(GO:0002399) |
0.1 | 0.2 | GO:0007113 | endomitotic cell cycle(GO:0007113) |
0.1 | 0.3 | GO:0030070 | insulin processing(GO:0030070) |
0.1 | 0.8 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.1 | 0.4 | GO:2000676 | response to manganese-induced endoplasmic reticulum stress(GO:1990737) positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.1 | 0.3 | GO:0002528 | regulation of vascular permeability involved in acute inflammatory response(GO:0002528) |
0.1 | 0.2 | GO:0033499 | galactose catabolic process via UDP-galactose(GO:0033499) |
0.1 | 0.2 | GO:0060127 | subthalamic nucleus development(GO:0021763) prolactin secreting cell differentiation(GO:0060127) pulmonary vein morphogenesis(GO:0060577) superior vena cava morphogenesis(GO:0060578) |
0.1 | 0.4 | GO:0050955 | thermoception(GO:0050955) |
0.1 | 1.5 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.1 | 0.8 | GO:0010579 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.1 | 1.3 | GO:0007379 | segment specification(GO:0007379) |
0.1 | 0.1 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.1 | 0.2 | GO:2001027 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) negative regulation of endothelial cell chemotaxis(GO:2001027) |
0.1 | 0.1 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.1 | 0.4 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.0 | 0.1 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.0 | 0.4 | GO:0044800 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.0 | 1.1 | GO:0097369 | sodium ion import(GO:0097369) |
0.0 | 10.8 | GO:0031424 | keratinization(GO:0031424) |
0.0 | 0.4 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.0 | 0.1 | GO:0036510 | trimming of terminal mannose on C branch(GO:0036510) |
0.0 | 0.2 | GO:0035498 | carnosine metabolic process(GO:0035498) |
0.0 | 0.1 | GO:2001025 | response to cyclosporin A(GO:1905237) positive regulation of response to drug(GO:2001025) |
0.0 | 7.5 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.0 | 0.2 | GO:0071351 | interleukin-18-mediated signaling pathway(GO:0035655) cellular response to interleukin-18(GO:0071351) |
0.0 | 0.3 | GO:0010816 | substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
0.0 | 0.4 | GO:0051454 | pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
0.0 | 0.8 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.0 | 0.3 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.0 | 0.6 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
0.0 | 0.2 | GO:0061580 | colon epithelial cell migration(GO:0061580) |
0.0 | 0.3 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
0.0 | 0.2 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
0.0 | 0.4 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.0 | 0.1 | GO:0060573 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.0 | 1.6 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.0 | 0.6 | GO:2000172 | regulation of branching morphogenesis of a nerve(GO:2000172) |
0.0 | 0.2 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
0.0 | 0.4 | GO:1904970 | brush border assembly(GO:1904970) |
0.0 | 0.6 | GO:0032740 | positive regulation of interleukin-17 production(GO:0032740) |
0.0 | 0.4 | GO:0050957 | equilibrioception(GO:0050957) |
0.0 | 0.2 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.0 | 0.6 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.0 | 0.4 | GO:0086024 | adrenergic receptor signaling pathway involved in positive regulation of heart rate(GO:0086024) |
0.0 | 0.1 | GO:0036245 | cellular response to menadione(GO:0036245) |
0.0 | 0.3 | GO:0097068 | response to thyroxine(GO:0097068) response to L-phenylalanine derivative(GO:1904386) |
0.0 | 0.3 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.0 | 0.2 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
0.0 | 0.4 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
0.0 | 1.2 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.0 | 0.4 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.0 | 0.1 | GO:2000342 | negative regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000342) |
0.0 | 0.3 | GO:0071477 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
0.0 | 0.3 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
0.0 | 2.7 | GO:0002292 | T cell differentiation involved in immune response(GO:0002292) |
0.0 | 0.6 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.0 | 0.1 | GO:0051037 | regulation of transcription involved in meiotic cell cycle(GO:0051037) |
0.0 | 0.3 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
0.0 | 0.6 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.0 | 0.3 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
0.0 | 0.1 | GO:0050928 | negative regulation of positive chemotaxis(GO:0050928) |
0.0 | 0.3 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.0 | 0.4 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.0 | 0.3 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
0.0 | 0.2 | GO:1902950 | regulation of dendritic spine maintenance(GO:1902950) negative regulation of dendritic spine maintenance(GO:1902951) |
0.0 | 0.9 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.0 | 0.7 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.0 | 0.2 | GO:1903826 | arginine transmembrane transport(GO:1903826) |
0.0 | 0.2 | GO:0035962 | response to interleukin-13(GO:0035962) |
0.0 | 0.3 | GO:0000270 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.0 | 0.3 | GO:0043418 | homocysteine catabolic process(GO:0043418) |
0.0 | 2.0 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.0 | 0.4 | GO:2001300 | lipoxin metabolic process(GO:2001300) |
0.0 | 0.2 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.0 | 0.2 | GO:0048769 | sarcomerogenesis(GO:0048769) |
0.0 | 1.3 | GO:0033198 | response to ATP(GO:0033198) |
0.0 | 0.3 | GO:0010746 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
0.0 | 0.1 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) negative regulation of icosanoid secretion(GO:0032304) negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.0 | 0.4 | GO:0090204 | protein localization to nuclear pore(GO:0090204) |
0.0 | 0.3 | GO:0070233 | negative regulation of T cell apoptotic process(GO:0070233) |
0.0 | 0.2 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) |
0.0 | 0.3 | GO:0051013 | microtubule severing(GO:0051013) |
0.0 | 1.1 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.0 | 0.1 | GO:0070563 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) negative regulation of response to alcohol(GO:1901420) |
0.0 | 0.7 | GO:0035590 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.0 | 0.4 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.0 | 0.2 | GO:0009441 | glycolate metabolic process(GO:0009441) |
0.0 | 0.6 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.0 | 1.4 | GO:0002260 | lymphocyte homeostasis(GO:0002260) |
0.0 | 0.2 | GO:0044565 | dendritic cell proliferation(GO:0044565) |
0.0 | 0.1 | GO:0039007 | pronephric nephron morphogenesis(GO:0039007) pronephric nephron tubule morphogenesis(GO:0039008) pronephric nephron tubule development(GO:0039020) pronephric duct development(GO:0039022) pronephric duct morphogenesis(GO:0039023) Kupffer's vesicle development(GO:0070121) |
0.0 | 0.2 | GO:0000117 | regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
0.0 | 0.1 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
0.0 | 0.1 | GO:0010607 | negative regulation of cytoplasmic mRNA processing body assembly(GO:0010607) |
0.0 | 0.1 | GO:0036233 | glycine import(GO:0036233) |
0.0 | 0.2 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.0 | 0.6 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
0.0 | 0.3 | GO:0051256 | mitotic spindle midzone assembly(GO:0051256) |
0.0 | 0.1 | GO:0097534 | lymphoid lineage cell migration(GO:0097534) lymphoid lineage cell migration into thymus(GO:0097535) regulation of positive thymic T cell selection(GO:1902232) |
0.0 | 0.6 | GO:0035886 | vascular smooth muscle cell differentiation(GO:0035886) |
0.0 | 0.5 | GO:0002820 | negative regulation of adaptive immune response(GO:0002820) |
0.0 | 0.1 | GO:0072709 | cellular response to sorbitol(GO:0072709) |
0.0 | 0.2 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.0 | 0.3 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.0 | 0.4 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.0 | 0.1 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.0 | 0.2 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.0 | 0.4 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.0 | 0.1 | GO:1904828 | regulation of phenotypic switching by transcription from RNA polymerase II promoter(GO:0100057) regulation of hydrogen sulfide biosynthetic process(GO:1904826) positive regulation of hydrogen sulfide biosynthetic process(GO:1904828) |
0.0 | 0.2 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.0 | 0.1 | GO:0021778 | oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
0.0 | 0.3 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.0 | 0.3 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.0 | 0.2 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.0 | 0.0 | GO:0019230 | proprioception(GO:0019230) |
0.0 | 0.2 | GO:0060368 | regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060368) |
0.0 | 1.0 | GO:0006409 | tRNA export from nucleus(GO:0006409) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
0.0 | 0.3 | GO:0001765 | membrane raft assembly(GO:0001765) |
0.0 | 0.2 | GO:0035965 | cardiolipin acyl-chain remodeling(GO:0035965) |
0.0 | 0.2 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.0 | 0.5 | GO:0002192 | cap-independent translational initiation(GO:0002190) IRES-dependent translational initiation(GO:0002192) IRES-dependent viral translational initiation(GO:0075522) |
0.0 | 0.9 | GO:0030220 | platelet formation(GO:0030220) |
0.0 | 0.2 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.0 | 1.0 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.0 | 0.3 | GO:0045974 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.0 | 1.2 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
0.0 | 0.7 | GO:0035994 | response to muscle stretch(GO:0035994) |
0.0 | 0.1 | GO:0060737 | prostate epithelial cord elongation(GO:0060523) prostate gland morphogenetic growth(GO:0060737) |
0.0 | 0.2 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.0 | 0.3 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.0 | 1.8 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.0 | 0.2 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.5 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.0 | 0.1 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.0 | 0.6 | GO:0032098 | regulation of appetite(GO:0032098) |
0.0 | 0.2 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.0 | 0.1 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.0 | 0.2 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.0 | 0.1 | GO:0002677 | negative regulation of chronic inflammatory response(GO:0002677) |
0.0 | 0.6 | GO:0001556 | oocyte maturation(GO:0001556) |
0.0 | 0.2 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.0 | 0.7 | GO:0006337 | nucleosome disassembly(GO:0006337) |
0.0 | 0.8 | GO:0061014 | regulation of mRNA catabolic process(GO:0061013) positive regulation of mRNA catabolic process(GO:0061014) |
0.0 | 0.2 | GO:0043555 | regulation of translation in response to stress(GO:0043555) |
0.0 | 0.1 | GO:0023016 | signal transduction by trans-phosphorylation(GO:0023016) |
0.0 | 0.2 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.0 | 0.1 | GO:0006288 | base-excision repair, DNA ligation(GO:0006288) |
0.0 | 0.7 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.0 | 0.4 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.0 | 0.1 | GO:1903464 | signal transduction involved in intra-S DNA damage checkpoint(GO:0072428) negative regulation of cell cycle checkpoint(GO:1901977) regulation of mitotic cell cycle DNA replication(GO:1903463) negative regulation of mitotic cell cycle DNA replication(GO:1903464) response to bisphenol A(GO:1903925) cellular response to bisphenol A(GO:1903926) negative regulation of DNA damage checkpoint(GO:2000002) |
0.0 | 0.2 | GO:2000765 | regulation of cytoplasmic translation(GO:2000765) |
0.0 | 0.4 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.0 | 0.3 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
0.0 | 0.0 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.0 | 0.7 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.0 | 0.3 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.0 | 1.3 | GO:0071349 | interleukin-12-mediated signaling pathway(GO:0035722) response to interleukin-12(GO:0070671) cellular response to interleukin-12(GO:0071349) |
0.0 | 0.3 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.0 | 0.1 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.0 | 0.2 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.0 | 0.2 | GO:0019375 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.0 | 1.0 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
0.0 | 0.5 | GO:0050482 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.0 | 0.1 | GO:0071233 | cellular response to leucine(GO:0071233) |
0.0 | 0.1 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.0 | 0.6 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.0 | 0.3 | GO:0001675 | acrosome assembly(GO:0001675) |
0.0 | 0.1 | GO:2000653 | histone H3-K79 methylation(GO:0034729) regulation of genetic imprinting(GO:2000653) |
0.0 | 0.3 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.0 | 0.1 | GO:0021993 | initiation of neural tube closure(GO:0021993) |
0.0 | 0.1 | GO:0034287 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.0 | 0.1 | GO:0048664 | neuron fate determination(GO:0048664) |
0.0 | 0.3 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.0 | 0.2 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.0 | 0.1 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.0 | 0.6 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.0 | 0.1 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.0 | 0.1 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.0 | 0.1 | GO:0051096 | positive regulation of helicase activity(GO:0051096) |
0.0 | 2.1 | GO:0090630 | activation of GTPase activity(GO:0090630) |
0.0 | 0.2 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
0.0 | 0.1 | GO:0019060 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
0.0 | 0.5 | GO:0022400 | regulation of rhodopsin mediated signaling pathway(GO:0022400) |
0.0 | 0.2 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
0.0 | 0.1 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
0.0 | 0.2 | GO:0000338 | protein deneddylation(GO:0000338) |
0.0 | 0.2 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.0 | 0.1 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.0 | 0.3 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.0 | 0.0 | GO:0006286 | base-excision repair, base-free sugar-phosphate removal(GO:0006286) telomere maintenance via base-excision repair(GO:0097698) |
0.0 | 0.2 | GO:0030299 | intestinal cholesterol absorption(GO:0030299) intestinal lipid absorption(GO:0098856) |
0.0 | 0.1 | GO:0097647 | calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
0.0 | 0.1 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.0 | 0.1 | GO:0090063 | positive regulation of microtubule nucleation(GO:0090063) |
0.0 | 0.3 | GO:0051923 | sulfation(GO:0051923) |
0.0 | 0.1 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
0.0 | 1.7 | GO:0051291 | protein heterooligomerization(GO:0051291) |
0.0 | 0.2 | GO:0030091 | protein repair(GO:0030091) |
0.0 | 0.8 | GO:0042100 | B cell proliferation(GO:0042100) |
0.0 | 0.4 | GO:0048240 | sperm capacitation(GO:0048240) |
0.0 | 0.1 | GO:0038172 | interleukin-33-mediated signaling pathway(GO:0038172) |
0.0 | 0.1 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.0 | 0.3 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) |
0.0 | 1.3 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.0 | 0.2 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.0 | 0.0 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.0 | 0.0 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.0 | 0.2 | GO:0015871 | choline transport(GO:0015871) |
0.0 | 0.1 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.0 | 0.1 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.0 | 0.2 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.0 | 0.4 | GO:0021983 | pituitary gland development(GO:0021983) |
0.0 | 0.1 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.0 | 0.3 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
0.0 | 0.0 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.0 | 0.0 | GO:0021825 | substrate-dependent cerebral cortex tangential migration(GO:0021825) |
0.0 | 0.3 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.0 | 0.1 | GO:0048263 | determination of dorsal identity(GO:0048263) |
0.0 | 0.2 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.0 | 0.4 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.0 | 0.1 | GO:0002438 | acute inflammatory response to antigenic stimulus(GO:0002438) |
0.0 | 0.2 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.0 | 0.1 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.0 | 0.2 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.0 | 0.1 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
0.0 | 0.7 | GO:0016574 | histone ubiquitination(GO:0016574) |
0.0 | 0.2 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.0 | 0.1 | GO:0046931 | pore complex assembly(GO:0046931) |
0.0 | 0.1 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.0 | 3.8 | GO:0007608 | sensory perception of smell(GO:0007608) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 5.1 | GO:0036021 | endolysosome lumen(GO:0036021) |
0.5 | 1.4 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.4 | 2.3 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.3 | 1.7 | GO:0071756 | IgM immunoglobulin complex(GO:0071753) IgM immunoglobulin complex, circulating(GO:0071754) pentameric IgM immunoglobulin complex(GO:0071756) |
0.3 | 2.1 | GO:0031523 | Myb complex(GO:0031523) |
0.3 | 3.3 | GO:0032010 | phagolysosome(GO:0032010) |
0.3 | 9.6 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.2 | 4.6 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.2 | 1.3 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.2 | 0.6 | GO:0032997 | Fc receptor complex(GO:0032997) Fc-epsilon receptor I complex(GO:0032998) |
0.2 | 0.6 | GO:0002141 | stereocilia ankle link(GO:0002141) USH2 complex(GO:1990696) |
0.2 | 2.3 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.2 | 0.9 | GO:1990667 | PCSK9-AnxA2 complex(GO:1990667) |
0.2 | 12.1 | GO:0001772 | immunological synapse(GO:0001772) |
0.1 | 3.0 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.1 | 2.1 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.1 | 0.6 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.1 | 0.4 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.1 | 1.8 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.1 | 2.1 | GO:0042584 | chromaffin granule membrane(GO:0042584) |
0.1 | 4.9 | GO:0001891 | phagocytic cup(GO:0001891) |
0.1 | 0.4 | GO:0033290 | eukaryotic 48S preinitiation complex(GO:0033290) translation initiation ternary complex(GO:0044207) |
0.1 | 0.4 | GO:0090651 | apical cytoplasm(GO:0090651) |
0.1 | 0.7 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
0.1 | 0.3 | GO:1990332 | Ire1 complex(GO:1990332) IRE1-RACK1-PP2A complex(GO:1990630) |
0.1 | 0.4 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) proton-transporting ATP synthase complex(GO:0045259) |
0.1 | 2.0 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.1 | 2.2 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.1 | 1.7 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.1 | 0.4 | GO:0044307 | dendritic branch(GO:0044307) |
0.1 | 4.3 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.1 | 0.9 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
0.1 | 1.4 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.1 | 0.2 | GO:0034657 | GID complex(GO:0034657) |
0.1 | 0.8 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.1 | 0.4 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.1 | 0.3 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.1 | 0.3 | GO:0035841 | new growing cell tip(GO:0035841) |
0.1 | 0.6 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.1 | 1.1 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.1 | 0.5 | GO:1990037 | Lewy body core(GO:1990037) |
0.1 | 0.5 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.1 | 0.8 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.1 | 0.6 | GO:0060171 | stereocilium membrane(GO:0060171) |
0.1 | 0.3 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
0.1 | 0.4 | GO:0034688 | integrin alphaM-beta2 complex(GO:0034688) |
0.0 | 0.6 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.0 | 2.7 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.0 | 0.6 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.0 | 4.2 | GO:0045095 | keratin filament(GO:0045095) |
0.0 | 5.6 | GO:0005882 | intermediate filament(GO:0005882) |
0.0 | 0.2 | GO:0034677 | integrin alpha7-beta1 complex(GO:0034677) |
0.0 | 0.4 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.0 | 1.9 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.0 | 2.1 | GO:0097546 | ciliary base(GO:0097546) |
0.0 | 5.1 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.0 | 6.5 | GO:0035579 | specific granule membrane(GO:0035579) |
0.0 | 0.3 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.0 | 0.7 | GO:0030008 | TRAPP complex(GO:0030008) |
0.0 | 0.5 | GO:0036128 | CatSper complex(GO:0036128) |
0.0 | 0.3 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.0 | 0.2 | GO:0002945 | cyclin K-CDK13 complex(GO:0002945) |
0.0 | 0.2 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.0 | 0.4 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.0 | 13.2 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 1.4 | GO:0005605 | basal lamina(GO:0005605) |
0.0 | 0.2 | GO:0005873 | plus-end kinesin complex(GO:0005873) |
0.0 | 0.7 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.0 | 0.8 | GO:0097225 | sperm midpiece(GO:0097225) |
0.0 | 0.3 | GO:0097452 | GAIT complex(GO:0097452) |
0.0 | 0.1 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
0.0 | 1.0 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.0 | 0.2 | GO:0070081 | clathrin-sculpted monoamine transport vesicle(GO:0070081) clathrin-sculpted monoamine transport vesicle membrane(GO:0070083) |
0.0 | 0.3 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.0 | 0.6 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.0 | 0.1 | GO:0097422 | tubular endosome(GO:0097422) |
0.0 | 0.9 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.0 | 0.1 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.0 | 0.4 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.0 | 0.4 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.0 | 0.6 | GO:0035102 | PRC1 complex(GO:0035102) |
0.0 | 0.4 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.0 | 0.6 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.0 | 1.3 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 0.5 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.0 | 1.4 | GO:0090544 | BAF-type complex(GO:0090544) |
0.0 | 0.9 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.0 | 0.3 | GO:0060091 | kinocilium(GO:0060091) |
0.0 | 0.1 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.0 | 3.3 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.0 | 0.1 | GO:0035061 | interchromatin granule(GO:0035061) |
0.0 | 0.5 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.0 | 0.2 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.0 | 0.3 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 0.2 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.0 | 0.1 | GO:0055087 | Ski complex(GO:0055087) |
0.0 | 0.1 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.0 | 0.4 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.0 | 0.1 | GO:0036502 | Derlin-1-VIMP complex(GO:0036502) |
0.0 | 0.9 | GO:0002102 | podosome(GO:0002102) |
0.0 | 0.6 | GO:0031519 | PcG protein complex(GO:0031519) |
0.0 | 0.3 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.0 | 0.2 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.0 | 0.2 | GO:0005688 | U6 snRNP(GO:0005688) |
0.0 | 3.1 | GO:0072562 | blood microparticle(GO:0072562) |
0.0 | 0.1 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.0 | 0.6 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.0 | 0.1 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) CNTFR-CLCF1 complex(GO:0097059) |
0.0 | 1.3 | GO:0035580 | specific granule lumen(GO:0035580) |
0.0 | 0.4 | GO:1904724 | tertiary granule lumen(GO:1904724) |
0.0 | 3.5 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.0 | 0.1 | GO:0033165 | interphotoreceptor matrix(GO:0033165) |
0.0 | 1.3 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
0.0 | 0.1 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.0 | 0.3 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.0 | 0.5 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.0 | 0.2 | GO:0090543 | Flemming body(GO:0090543) |
0.0 | 0.2 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.0 | 0.1 | GO:0045180 | basal cortex(GO:0045180) |
0.0 | 2.6 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.0 | 0.3 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.0 | 0.4 | GO:0097228 | sperm principal piece(GO:0097228) |
0.0 | 1.0 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.0 | 0.4 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
0.0 | 0.1 | GO:0042382 | paraspeckles(GO:0042382) |
0.0 | 2.2 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.0 | 1.2 | GO:0005643 | nuclear pore(GO:0005643) |
0.0 | 0.1 | GO:0030057 | desmosome(GO:0030057) |
0.0 | 1.8 | GO:0016605 | PML body(GO:0016605) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.0 | 5.9 | GO:0005174 | CD40 receptor binding(GO:0005174) |
1.3 | 6.5 | GO:0005350 | pyrimidine nucleobase transmembrane transporter activity(GO:0005350) |
0.8 | 3.2 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.8 | 2.4 | GO:0004500 | dopamine beta-monooxygenase activity(GO:0004500) |
0.6 | 3.0 | GO:0004666 | prostaglandin-endoperoxide synthase activity(GO:0004666) |
0.4 | 4.4 | GO:0070892 | lipoteichoic acid receptor activity(GO:0070892) |
0.3 | 2.1 | GO:0052828 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity(GO:0016316) inositol-1,3,4-trisphosphate 4-phosphatase activity(GO:0017161) phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) inositol-3,4-bisphosphate 4-phosphatase activity(GO:0052828) |
0.3 | 1.0 | GO:0004108 | citrate (Si)-synthase activity(GO:0004108) citrate synthase activity(GO:0036440) |
0.3 | 1.3 | GO:0070119 | ciliary neurotrophic factor binding(GO:0070119) |
0.3 | 8.1 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.3 | 0.8 | GO:0004574 | oligo-1,6-glucosidase activity(GO:0004574) |
0.2 | 5.6 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.2 | 8.0 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.2 | 1.2 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.2 | 2.2 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.2 | 1.2 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
0.2 | 0.8 | GO:0071885 | N-terminal protein N-methyltransferase activity(GO:0071885) |
0.2 | 1.5 | GO:0038051 | glucocorticoid receptor activity(GO:0004883) glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity(GO:0038051) |
0.2 | 0.9 | GO:0004167 | dopachrome isomerase activity(GO:0004167) |
0.2 | 1.6 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.2 | 1.6 | GO:0030021 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.2 | 5.8 | GO:0031489 | myosin V binding(GO:0031489) |
0.2 | 1.5 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.2 | 0.8 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.2 | 0.5 | GO:0050528 | acyloxyacyl hydrolase activity(GO:0050528) |
0.2 | 0.9 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
0.1 | 1.2 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.1 | 1.0 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.1 | 0.5 | GO:0061752 | telomeric repeat-containing RNA binding(GO:0061752) |
0.1 | 0.9 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.1 | 1.1 | GO:1990254 | keratin filament binding(GO:1990254) |
0.1 | 0.5 | GO:0001632 | leukotriene B4 receptor activity(GO:0001632) |
0.1 | 1.8 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.1 | 0.3 | GO:0047787 | delta4-3-oxosteroid 5beta-reductase activity(GO:0047787) |
0.1 | 1.7 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.1 | 1.1 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.1 | 0.5 | GO:0016495 | C-X3-C chemokine receptor activity(GO:0016495) |
0.1 | 4.0 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.1 | 1.3 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.1 | 1.4 | GO:0030274 | LIM domain binding(GO:0030274) |
0.1 | 4.6 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.1 | 0.6 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.1 | 0.3 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.1 | 0.9 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.1 | 0.5 | GO:0023023 | MHC protein complex binding(GO:0023023) MHC class I protein complex binding(GO:0023024) |
0.1 | 1.9 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 2.6 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.1 | 6.3 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.1 | 5.5 | GO:0043236 | laminin binding(GO:0043236) |
0.1 | 0.9 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.1 | 0.3 | GO:0015616 | DNA translocase activity(GO:0015616) |
0.1 | 0.9 | GO:0031013 | troponin I binding(GO:0031013) |
0.1 | 1.8 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.1 | 0.3 | GO:0097689 | iron channel activity(GO:0097689) |
0.1 | 1.2 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.1 | 0.4 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.1 | 4.2 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 0.9 | GO:0004064 | arylesterase activity(GO:0004064) |
0.1 | 0.3 | GO:0008665 | 2'-phosphotransferase activity(GO:0008665) |
0.1 | 0.3 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.1 | 1.2 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.1 | 0.4 | GO:0004464 | leukotriene-C4 synthase activity(GO:0004464) |
0.1 | 0.2 | GO:0042008 | interleukin-18 receptor activity(GO:0042008) |
0.1 | 0.5 | GO:0004504 | peptidylglycine monooxygenase activity(GO:0004504) peptidylamidoglycolate lyase activity(GO:0004598) |
0.1 | 0.2 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.1 | 0.6 | GO:0019863 | IgE binding(GO:0019863) |
0.1 | 2.0 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.1 | 0.4 | GO:0008955 | peptidoglycan glycosyltransferase activity(GO:0008955) |
0.1 | 12.8 | GO:0003823 | antigen binding(GO:0003823) |
0.1 | 1.8 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.1 | 1.6 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.1 | 0.7 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.1 | 1.6 | GO:0000150 | recombinase activity(GO:0000150) |
0.1 | 0.3 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
0.1 | 0.4 | GO:0008281 | sulfonylurea receptor activity(GO:0008281) |
0.1 | 0.4 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.1 | 2.2 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.1 | 0.8 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.1 | 1.0 | GO:0015266 | protein channel activity(GO:0015266) |
0.1 | 2.3 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.1 | 0.2 | GO:0052853 | (S)-2-hydroxy-acid oxidase activity(GO:0003973) very-long-chain-(S)-2-hydroxy-acid oxidase activity(GO:0052852) long-chain-(S)-2-hydroxy-long-chain-acid oxidase activity(GO:0052853) medium-chain-(S)-2-hydroxy-acid oxidase activity(GO:0052854) |
0.1 | 1.3 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.1 | 0.5 | GO:0099580 | ion antiporter activity involved in regulation of postsynaptic membrane potential(GO:0099580) |
0.1 | 0.2 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.1 | 0.4 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.1 | 0.6 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
0.1 | 0.3 | GO:0047256 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity(GO:0008457) lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity(GO:0047256) |
0.1 | 0.5 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.1 | 0.5 | GO:0015065 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.1 | 1.7 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.1 | 0.3 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
0.1 | 0.4 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.0 | 0.1 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.0 | 0.2 | GO:0031728 | CCR3 chemokine receptor binding(GO:0031728) |
0.0 | 0.5 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.0 | 0.2 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.0 | 3.2 | GO:0005549 | odorant binding(GO:0005549) |
0.0 | 0.1 | GO:0005139 | interleukin-7 receptor binding(GO:0005139) |
0.0 | 0.7 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.0 | 0.6 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.0 | 0.3 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.0 | 0.4 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.0 | 0.2 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
0.0 | 1.3 | GO:0001011 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
0.0 | 1.3 | GO:0042287 | MHC protein binding(GO:0042287) |
0.0 | 0.2 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.0 | 0.6 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
0.0 | 0.7 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.0 | 0.2 | GO:0051022 | GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.0 | 0.4 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.0 | 0.6 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.0 | 0.7 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.0 | 0.1 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
0.0 | 0.3 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.0 | 0.8 | GO:0008494 | translation activator activity(GO:0008494) |
0.0 | 0.6 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
0.0 | 0.2 | GO:0003943 | N-acetylgalactosamine-4-sulfatase activity(GO:0003943) |
0.0 | 0.5 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.0 | 0.5 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.0 | 0.1 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
0.0 | 0.5 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.0 | 3.0 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.0 | 2.6 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.0 | 0.2 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.0 | 0.2 | GO:0008466 | glycogenin glucosyltransferase activity(GO:0008466) |
0.0 | 0.2 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.0 | 0.4 | GO:0001851 | complement component C3b binding(GO:0001851) |
0.0 | 0.4 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.0 | 0.7 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.0 | 0.2 | GO:0097199 | cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097199) |
0.0 | 1.2 | GO:0017166 | vinculin binding(GO:0017166) |
0.0 | 1.0 | GO:0032041 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.0 | 0.4 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.0 | 1.1 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.0 | 0.1 | GO:0002046 | opsin binding(GO:0002046) |
0.0 | 0.5 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.0 | 0.1 | GO:0004522 | ribonuclease A activity(GO:0004522) |
0.0 | 0.5 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.0 | 0.2 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.0 | 1.6 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.0 | 1.2 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.0 | 0.2 | GO:0039552 | RIG-I binding(GO:0039552) |
0.0 | 0.2 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
0.0 | 0.2 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.0 | 0.3 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.0 | 0.1 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.0 | 0.4 | GO:0047144 | 2-acylglycerol-3-phosphate O-acyltransferase activity(GO:0047144) |
0.0 | 0.1 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.0 | 0.2 | GO:0070728 | leucine binding(GO:0070728) |
0.0 | 0.2 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.0 | 0.8 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.0 | 0.6 | GO:0005522 | profilin binding(GO:0005522) |
0.0 | 0.8 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.0 | 0.2 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.0 | 0.4 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.0 | 0.9 | GO:0034061 | DNA polymerase activity(GO:0034061) |
0.0 | 0.9 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.0 | 0.1 | GO:0004008 | copper-exporting ATPase activity(GO:0004008) phosphoglycerate kinase activity(GO:0004618) copper-transporting ATPase activity(GO:0043682) |
0.0 | 0.5 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.0 | 0.6 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.0 | 1.2 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.0 | 0.4 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.0 | 0.4 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.0 | 0.2 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
0.0 | 0.1 | GO:0004487 | methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
0.0 | 0.6 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 0.1 | GO:0001156 | RNA polymerase III transcription factor binding(GO:0001025) TFIIIC-class transcription factor binding(GO:0001156) |
0.0 | 0.2 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.0 | 0.1 | GO:0008431 | vitamin E binding(GO:0008431) |
0.0 | 0.3 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.0 | 0.3 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.0 | 0.3 | GO:0034485 | phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity(GO:0034485) |
0.0 | 0.9 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.0 | 1.9 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.0 | 0.7 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.0 | 1.9 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
0.0 | 0.1 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
0.0 | 0.2 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) |
0.0 | 0.8 | GO:0038191 | neuropilin binding(GO:0038191) |
0.0 | 0.1 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
0.0 | 0.7 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.0 | 0.3 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.0 | 0.1 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 0.8 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.0 | 1.1 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.0 | 0.2 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.0 | 2.3 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.0 | 1.0 | GO:0000049 | tRNA binding(GO:0000049) |
0.0 | 0.1 | GO:0005477 | pyruvate secondary active transmembrane transporter activity(GO:0005477) |
0.0 | 1.4 | GO:0043022 | ribosome binding(GO:0043022) |
0.0 | 0.7 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.0 | 0.7 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.0 | 0.2 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.0 | 0.7 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.0 | 0.6 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.0 | 0.2 | GO:0001733 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
0.0 | 0.3 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.0 | 0.2 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
0.0 | 0.1 | GO:0038052 | RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding(GO:0038052) |
0.0 | 6.1 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.0 | 0.1 | GO:0000035 | acyl binding(GO:0000035) |
0.0 | 0.0 | GO:0032093 | SAM domain binding(GO:0032093) |
0.0 | 6.3 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.0 | 0.1 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.0 | 0.1 | GO:1902271 | D3 vitamins binding(GO:1902271) |
0.0 | 0.2 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.0 | 0.1 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
0.0 | 1.1 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.0 | 0.2 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.0 | 0.2 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.0 | 0.1 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) |
0.0 | 0.2 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.0 | 0.2 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 0.1 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.0 | 0.2 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.0 | 0.5 | GO:0005123 | death receptor binding(GO:0005123) |
0.0 | 0.1 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.0 | 0.1 | GO:0044736 | acid-sensing ion channel activity(GO:0044736) |
0.0 | 0.3 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.0 | 0.1 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.0 | 0.0 | GO:0052739 | phosphatidylserine 1-acylhydrolase activity(GO:0052739) |
0.0 | 0.3 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.0 | 0.5 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.0 | 5.3 | GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) |
0.0 | 1.1 | GO:0008080 | N-acetyltransferase activity(GO:0008080) |
0.0 | 0.1 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.0 | 0.1 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.0 | 0.1 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.0 | 0.4 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.0 | 1.0 | GO:0003724 | RNA helicase activity(GO:0003724) |
0.0 | 0.0 | GO:0052816 | medium-chain acyl-CoA hydrolase activity(GO:0052815) long-chain acyl-CoA hydrolase activity(GO:0052816) |
0.0 | 0.4 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.0 | 0.0 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.0 | 0.2 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.0 | 0.1 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
0.0 | 0.0 | GO:0005260 | channel-conductance-controlling ATPase activity(GO:0005260) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.2 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.1 | 8.5 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.1 | 5.3 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.1 | 0.3 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.1 | 2.1 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 3.3 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.1 | 7.5 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.1 | 0.8 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.1 | 2.5 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 2.8 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 4.5 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 1.9 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.1 | 3.7 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.1 | 2.7 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.0 | 0.4 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 1.4 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.0 | 5.1 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.0 | 0.3 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 1.0 | PID EPO PATHWAY | EPO signaling pathway |
0.0 | 0.3 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 0.6 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.0 | 1.9 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 4.6 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.0 | 3.3 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.0 | 1.2 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.0 | 1.1 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.0 | 2.3 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.0 | 1.5 | PID ENDOTHELIN PATHWAY | Endothelins |
0.0 | 1.6 | PID ARF6 PATHWAY | Arf6 signaling events |
0.0 | 1.4 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.7 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.0 | 1.9 | PID PLK1 PATHWAY | PLK1 signaling events |
0.0 | 0.4 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 2.1 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.0 | 0.9 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.0 | 1.6 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.0 | 0.4 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 0.6 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.0 | 4.6 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 1.4 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.0 | 0.4 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.0 | 1.3 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.0 | 0.4 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.0 | 0.1 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 0.2 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.0 | 0.3 | PID IFNG PATHWAY | IFN-gamma pathway |
0.0 | 0.9 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.0 | 0.6 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.0 | 1.0 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 0.3 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.0 | 0.4 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.0 | 0.3 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.0 | 0.1 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.0 | 0.5 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.0 | 0.1 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 0.2 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 5.1 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.4 | 6.0 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.3 | 7.9 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.2 | 8.2 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.1 | 4.9 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 3.6 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.1 | 2.1 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.1 | 1.5 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.1 | 0.4 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.1 | 2.0 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.1 | 4.6 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.1 | 1.8 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.1 | 8.3 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 4.1 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 2.2 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 1.3 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 1.7 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.1 | 0.1 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.1 | 17.4 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 0.8 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.0 | 0.9 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.0 | 0.1 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.0 | 0.2 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.0 | 0.9 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.0 | 1.6 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 0.8 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.0 | 1.1 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.0 | 0.2 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.0 | 1.3 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.0 | 1.1 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.0 | 0.8 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.0 | 5.0 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.0 | 0.5 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.0 | 1.6 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.0 | 0.2 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.0 | 1.2 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.0 | 0.3 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.0 | 0.7 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.0 | 1.2 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.0 | 0.6 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.0 | 2.1 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 4.1 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 0.3 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.0 | 1.2 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.0 | 0.3 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.0 | 0.4 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.0 | 0.5 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.0 | 0.6 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.0 | 1.2 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.0 | 0.5 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.0 | 0.4 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.0 | 0.6 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.0 | 0.7 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 0.8 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.0 | 0.3 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.0 | 0.7 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF RAS | Genes involved in CREB phosphorylation through the activation of Ras |
0.0 | 0.5 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.0 | 0.6 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.0 | 0.4 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.0 | 1.1 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.0 | 0.5 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.0 | 0.3 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.0 | 0.2 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.0 | 3.3 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.0 | 1.6 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.0 | 0.7 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.0 | 1.0 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.0 | 0.9 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
0.0 | 0.9 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 0.3 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.0 | 1.1 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.0 | 4.0 | REACTOME TRANSLATION | Genes involved in Translation |
0.0 | 0.5 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.0 | 0.2 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.0 | 0.1 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.0 | 0.4 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.0 | 0.4 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.0 | 0.3 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.0 | 0.5 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.0 | 0.1 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.0 | 0.1 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.0 | 3.8 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.0 | 1.2 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 0.3 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.0 | 0.8 | REACTOME HEPARAN SULFATE HEPARIN HS GAG METABOLISM | Genes involved in Heparan sulfate/heparin (HS-GAG) metabolism |
0.0 | 0.3 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.0 | 1.6 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.0 | 0.3 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.0 | 0.6 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.0 | 0.2 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.0 | 0.5 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.0 | 0.2 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |